Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects
Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects
Active, not recruiting · NCT05239793 · Registry updated 2025-10-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Early phase 1 | 2025-10-27 | NCT05239793 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Milton S. Hershey Medical Center | 79 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Penn State Health Milton S. Hershey Medical Center | Hershey | United States | 31 |